vizz
Generic: aceclidine·Code: LNZ100
vizz: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LENZ Therapeutics, Inc. (LENZ) | Approved |
FDA Decisions
Approval(LENZ)
Frequently asked questions
Who is developing vizz?
vizz is being developed by LENZ Therapeutics, Inc..
What is vizz's latest FDA decision?
The most recent tracked FDA decision for vizz is Approval, dated July 31, 2025.
Get deeper analysis on vizz
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis